Empagliflozin in heart failure with a preserved ejection fraction
Anker SD, Butler J, Filippatos G, et al.
N Engl J Med. 27 August 2021
Leggi
Glucose-lowering therapy in patients with postpancreatitis diabetes mellitus: a nationwide population-based cohort study
Viggers R, Hasselstrøm Jensen M, Bering Laursen HV, et al.
Diabetes Care. 2021;44(9):2045-52
Leggi
Consensus report: definition and interpretation of remission in type 2 diabetes.
Riddle MC, Cefalu WT, Evans PH, et al.
Diabetologia. Pub. online 30 August 2021
Leggi
Once‐weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real‐world data from a diabetes out‐patient clinic
Hansen KB, Svendstrup M, Lund A, et al.
Diabet Med. Pub. online 4 August 2021
Leggi
Racial differences in all-cause mortality and future complications among people with diabetes: a systematic review and meta-analysis of data from more than 2.4 million individuals
Ezzatvar Y, Ramírez-Vélez R, Izquierdo M, et al.
Diabetologia. Pub. online 28 August 2021
Leggi
Long-term complications in youth¬onset type 2 diabetes – TODAY study group
Bjornstad P, Drews KL, Caprio S, et al.
N Engl J Med 2021;385:416-426.
Leggi
Racial, rural, and regional disparities in diabetes-related lower-extremity amputation rates, 2009–2017
Akinlotan MA, Primm K, Bolin JN, et al.
Diabetes Care. 2021;dc203135.
Leggi
The impact of hypoglycaemia on the quality of life of family members of adults with type 1 or type 2 diabetes – a qualitative systematic review
Valdersdorf Jensen M, Broadley M, Speight J, et al.
Diabet Med. 2021;e1466
Leggi
Risk of major congenital malformations or perinatal or neonatal death with insulin detemir versus other basal insulins in pregnant women with preexisting diabetes: the real-world EVOLVE study
Mathiesen ER, Ali N, Alibegovic AC, et al.
Diabetes Care. 2021;dc210472.
Leggi
The effect of dapagliflozin on albuminuria in DECLARE-TIMI 58
Mosenzon O, Wiviott SD, Heerspink HJL, et al.
Diabetes Care Pub. online 07 July 2021.
Leggi